Laupheim, Germany

Gert Haffner


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovative Contributions of Gert Haffner in Pharmaceutical Chemistry

Introduction

Gert Haffner, an esteemed inventor based in Laupheim, Germany, has made significant strides in the field of pharmaceutical chemistry. With a portfolio of two patents, Haffner's work focuses on the synthesis of high-purity chemical compounds that are essential for various medical applications.

Latest Patents

Among Haffner's notable patents is the innovation related to the chemical 1,3-Bis-(.beta.-ethylhexyl)-5-nitro-5-methyl-hexahydropyrimidine. This complex process involves the production of high-purity 1,3-bis-(.beta.-ethylhexyl)-5-amino-5-methyl-hexahydropyrimidine, commonly known as hexetidin. The process is executed by reacting 1,3-bis-(.beta.-ethylhexyl)-5-nitro-5-methyl-hexahydropyrimidine with naphthalene-1,5-disulphonic acid in a solvent. This reaction selectively precipitates an intermediate compound, which is then treated with aqueous alkali to yield 1,3-bis-(.beta.-ethylhexyl)-5-nitro-5-methyl-hexahydropyrimidine. Following hydrogenation, high-purity hexetidin is achieved.

Career Highlights

Gert Haffner's career is marked by his impactful contributions to pharmaceutical research and innovation. Working at Meditest Institut für Medizinisch Pharmazeutische Untersuchungen GmbH, he has positioned himself as a leader in the field of chemical synthesis and drug development. His efforts have paved the way for advancements in medical formulations that directly benefit patients.

Collaborations

Throughout his career, Gert Haffner has collaborated with esteemed colleagues like Fritz-Walter Lange and Jens Muller. These partnerships have facilitated a dynamic exchange of ideas and expertise, fostering an environment ripe for scientific breakthroughs within the pharmaceutical industry.

Conclusion

Gert Haffner's innovative spirit and dedication to improving pharmaceutical processes are commendable. His patented methods not only demonstrate his scientific prowess but also contribute to advancements in medical therapies. As he continues his work at Meditest Institut für Medizinisch Pharmazeutische Untersuchungen GmbH, the impact of his contributions will undoubtedly resonate within the scientific community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…